Untargeted Metabolomics Reveals a Lack Of Synergy between Nifurtimox and Eflornithine against Trypanosoma brucei

A non-targeted metabolomics-based approach is presented that enables the study of pathways in response to drug action with the aim of defining the mode of action of trypanocides. Eflornithine, a polyamine pathway inhibitor, and nifurtimox, whose mode of action involves its metabolic activation, are currently used in combination as first line treatment against stage 2, CNS-involved, human African trypanosomiasis (HAT). Drug action was assessed using an LC-MS based non-targeted metabolomics approach. Eflornithine revealed the expected changes to the polyamine pathway as well as several unexpected changes that point to pathways and metabolites not previously described in bloodstream form trypanosomes, including a lack of arginase activity and N-acetylated ornithine and putrescine. Nifurtimox was shown to be converted to a trinitrile metabolite indicative of metabolic activation, as well as inducing changes in levels of metabolites involved in carbohydrate and nucleotide metabolism. However, eflornithine and nifurtimox failed to synergise anti-trypanosomal activity in vitro, and the metabolomic changes associated with the combination are the sum of those found in each monotherapy with no indication of additional effects. The study reveals how untargeted metabolomics can yield rapid information on drug targets that could be adapted to any pharmacological situation.

[1]  M. Barrett,et al.  Human African trypanosomiasis: pharmacological re‐engagement with a neglected disease , 2007, British journal of pharmacology.

[2]  J. Wilting,et al.  Recent research on the biological activity of suramin. , 1993, Pharmacological reviews.

[3]  A. Fairlamb,et al.  In vivo effects of difluoromethylornithine on trypanothione and polyamine levels in bloodstream forms of Trypanosoma brucei. , 1987, Molecular and biochemical parasitology.

[4]  M. Barrett,et al.  Activity of Megazol, a Trypanocidal Nitroimidazole, Is Associated with DNA Damage , 2003, Antimicrobial Agents and Chemotherapy.

[5]  Eleanor C. Saunders,et al.  Central carbon metabolism of Leishmania parasites , 2010, Parasitology.

[6]  D. Nolan,et al.  The enzymes of the classical pentose phosphate pathway display differential activities in procyclic and bloodstream forms of Trypanosoma brucei , 1989, FEBS letters.

[7]  Douglas B. Kell,et al.  Discrimination of Modes of Action of Antifungal Substances by Use of Metabolic Footprinting , 2004, Applied and Environmental Microbiology.

[8]  A. Denicola,et al.  Mode of action of nifurtimox and N-oxide-containing heterocycles against Trypanosoma cruzi: is oxidative stress involved? , 2010, Biochemical pharmacology.

[9]  David G. Watson,et al.  A Molecular Mechanism for Eflornithine Resistance in African Trypanosomes , 2010, PLoS pathogens.

[10]  Marcela S. Sanchez,et al.  Polyamines as a defense mechanism against lipoperoxidation in Trypanosoma cruzi. , 2006, Acta tropica.

[11]  P. Bütikofer,et al.  Trypanosoma brucei: a model micro-organism to study eukaryotic phospholipid biosynthesis. , 2011, The FEBS journal.

[12]  M. Wilson,et al.  An Effect of Parasite-Encoded Arginase on the Outcome of Murine Cutaneous Leishmaniasis1 , 2007, The Journal of Immunology.

[13]  F. Chappuis,et al.  NECT Is Next: Implementing the New Drug Combination Therapy for Trypanosoma brucei gambiense Sleeping Sickness , 2010, PLoS neglected tropical diseases.

[14]  Lijie Sun,et al.  Systems-Scale Analysis Reveals Pathways Involved in Cellular Response to Methamphetamine , 2011, PloS one.

[15]  R. Docampo,et al.  Generation of superoxide anion and hydrogen peroxide induced by nifurtimox in Trypanosoma cruzi. , 1979, Archives of biochemistry and biophysics.

[16]  Jean-Charles Portais,et al.  Transketolase in Trypanosoma brucei. , 2011, Molecular and biochemical parasitology.

[17]  A. Fairlamb,et al.  Arsenical-resistant trypanosomes lack an unusual adenosine transporter , 1993, Nature.

[18]  R. Kaminsky,et al.  The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro. , 1997, Acta tropica.

[19]  M. Kron,et al.  Pentamidine: a review. , 1985, Reviews of infectious diseases.

[20]  C. Wang,et al.  Trypanosoma brucei brucei: characterization of an ODC null bloodstream form mutant and the action of alpha-difluoromethylornithine. , 1998, Experimental parasitology.

[21]  R. Klein,et al.  Hydrogen peroxide metabolism in Trypanosoma brucei. , 1986, Molecular and biochemical parasitology.

[22]  Manuel Llinás,et al.  Co-inhibition of Plasmodium falciparum S-Adenosylmethionine Decarboxylase/Ornithine Decarboxylase Reveals Perturbation-specific Compensatory Mechanisms by Transcriptome, Proteome, and Metabolome Analyses* , 2009, Journal of Biological Chemistry.

[23]  J. Doyle,et al.  Cultivation of bloodstream Trypanosoma brucei. , 1977, Bulletin of the World Health Organization.

[24]  N. Glansdorff,et al.  Bioinformatic analysis of an unusual gene-enzyme relationship in the arginine biosynthetic pathway among marine gamma proteobacteria: implications concerning the formation of N-acetylated intermediates in prokaryotes , 2006, BMC Genomics.

[25]  A. Albrecht,et al.  ACETYLORNITHINE DELTA-TRANSAMINASE. PARTIAL PURIFICATION AND REPRESSION BEHAVIOR. , 1964, The Journal of biological chemistry.

[26]  Bethan Hughes,et al.  2009 FDA drug approvals , 2010, Nature Reviews Drug Discovery.

[27]  B. Ullman,et al.  Inhibition profile of Leishmania mexicana arginase reveals differences with human arginase I. , 2011, International journal for parasitology.

[28]  M. Barrett,et al.  Metabolomic profiling using Orbitrap Fourier transform mass spectrometry with hydrophilic interaction chromatography: a method with wide applicability to analysis of biomolecules. , 2008, Rapid communications in mass spectrometry : RCM.

[29]  J. Doyle,et al.  African trypanosomes: cultivation of animal-infective Trypanosoma brucei in vitro. , 1977, Science.

[30]  M. Barrett,et al.  Transport of methionine in Trypanosoma brucei brucei. , 2000, Molecular and biochemical parasitology.

[31]  A. Pegg,et al.  Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine. Characterization of sequences at the inhibitor and coenzyme binding sites. , 1992, The Journal of biological chemistry.

[32]  N. Grishin,et al.  X-ray structure of ornithine decarboxylase from Trypanosoma brucei: the native structure and the structure in complex with alpha-difluoromethylornithine. , 1999, Biochemistry.

[33]  R. Breitling,et al.  PeakML/mzMatch: a file format, Java library, R library, and tool-chain for mass spectrometry data analysis. , 2011, Analytical chemistry.

[34]  L. Floeter-Winter,et al.  Genomic organisation and transcription characterisation of the gene encoding Leishmania (Leishmania) amazonensis arginase and its protein structure prediction. , 2002, International journal for parasitology.

[35]  M. Phillips,et al.  RNA Interference-Mediated Silencing of Ornithine Decarboxylase and Spermidine Synthase Genes in Trypanosoma brucei Provides Insight into Regulation of Polyamine Biosynthesis , 2009, Eukaryotic Cell.

[36]  B. Chait,et al.  Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. , 1985, Science.

[37]  S. Meshnick,et al.  DB75, a Novel Trypanocidal Agent, Disrupts Mitochondrial Function in Saccharomyces cerevisiae , 2004, Antimicrobial Agents and Chemotherapy.

[38]  M. Barrett,et al.  Semi-targeted analysis of metabolites using capillary-flow ion chromatography coupled to high-resolution mass spectrometry. , 2011, Rapid communications in mass spectrometry : RCM.

[39]  R. Breitling,et al.  Toward global metabolomics analysis with hydrophilic interaction liquid chromatography-mass spectrometry: improved metabolite identification by retention time prediction. , 2011, Analytical chemistry.

[40]  R. Abagyan,et al.  XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. , 2006, Analytical chemistry.

[41]  Rainer Breitling,et al.  Metabolomic systems biology of trypanosomes , 2010, Parasitology.

[42]  M. Barrett,et al.  Metabolomic analysis of trypanosomatid protozoa. , 2012, Molecular and biochemical parasitology.

[43]  B. Rodenko,et al.  2,N6-Disubstituted Adenosine Analogs with Antitrypanosomal and Antimalarial Activities , 2007, Antimicrobial Agents and Chemotherapy.

[44]  N Aranìbar,et al.  Automated mode-of-action detection by metabolic profiling. , 2001, Biochemical and biophysical research communications.

[45]  E. Fukusaki,et al.  GC‐MS‐based metabolomics reveals mechanism of action for hydrazine induced hepatotoxicity in rats , 2011, Journal of applied toxicology : JAT.

[46]  R. Mortara,et al.  Biochemical and biophysical properties of a highly active recombinant arginase from Leishmania (Leishmania) amazonensis and subcellular localization of native enzyme. , 2008, Molecular and biochemical parasitology.

[47]  R. Breitling,et al.  Towards an unbiased metabolic profiling of protozoan parasites: optimisation of a Leishmania sampling protocol for HILIC-orbitrap analysis , 2010, Analytical and bioanalytical chemistry.

[48]  Salah Ghabri,et al.  Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial , 2009, The Lancet.

[49]  S. Croft,et al.  The Distribution of Nifurtimox Across the Healthy and Trypanosome-Infected Murine Blood-Brain and Blood-Cerebrospinal Fluid Barriers , 2011, Journal of Pharmacology and Experimental Therapeutics.

[50]  H. Souzu.  Fluorescence polarization studies on Escherichia coli membrane stability and its relation to the resistance of the cell to freeze-thawing. II. Stabilization of the membranes by polyamines. , 1986, Biochimica et biophysica acta.

[51]  A. Bitonti,et al.  Necessity of antibody response in the treatment of African trypanosomiasis with alpha-difluoromethylornithine. , 1986, Biochemical pharmacology.

[52]  G. E. Cánepa,et al.  Trypanosoma cruzi: Oxidative stress induces arginine kinase expression. , 2006, Experimental parasitology.

[53]  P. McCann,et al.  In vivo effects of α-dl-Difluoromethylornithine on the metabolism and morphology of Trypanosoma brucei brucei , 1983 .

[54]  B. Hall,et al.  Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile Metabolites* , 2011, The Journal of Biological Chemistry.